IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
IRADIMED (NASDAQ: IRMD) has announced its upcoming 2024 second quarter financial results conference call, scheduled for August 1, 2024. The company will release its financial results before the market opens on that day. The conference call, hosted by Iradimed management, will begin at 12:00 p.m. Eastern Time.
Interested individuals can participate by registering through the provided link. Upon registration, participants will receive a dial-in number, unique pin, and instructions. The call will also be available in real-time via the internet on Iradimed's investor relations website. A recording of the call will be made available on the company's website following its completion.
IRADIMED (NASDAQ: IRMD) ha annunciato la sua prossima call per i risultati finanziari del secondo trimestre 2024, prevista per 1 agosto 2024. L'azienda pubblicherà i suoi risultati finanziari prima dell'apertura del mercato in quella data. La call sarà condotta dal management di Iradimed e inizierà alle 12:00 p.m. Eastern Time.
Le persone interessate possono partecipare registrandosi tramite il link fornito. Dopo la registrazione, i partecipanti riceveranno un numero per il collegamento, un pin unico e istruzioni. La chiamata sarà disponibile anche in tempo reale tramite internet sul sito web delle relazioni con gli investitori di Iradimed. Una registrazione della chiamata sarà resa disponibile sul sito dell'azienda al termine della stessa.
IRADIMED (NASDAQ: IRMD) ha anunciado su próxima llamada de resultados financieros para el segundo trimestre de 2024, programada para el 1 de agosto de 2024. La compañía publicará sus resultados financieros antes de la apertura del mercado ese día. La llamada, que será moderada por la dirección de Iradimed, comenzará a las 12:00 p.m. Eastern Time.
Las personas interesadas pueden participar registrándose a través del enlace proporcionado. Tras la inscripción, los participantes recibirán un número de marcación, un pin único y las instrucciones. La llamada también estará disponible en tiempo real a través de Internet en el sitio web de relaciones con inversores de Iradimed. Una grabación de la llamada estará disponible en el sitio web de la compañía después de su finalización.
IRADIMED (NASDAQ: IRMD)가 2024년 2분기 재무 결과 teleconference를 2024년 8월 1일에 개최한다고 발표했습니다. 회사는 이날 시장 개장 전에 재무 결과를 발표할 예정입니다. Iradimed 경영진이 주재하는 이 전화 회의는 동부 표준시 기준 오후 12시에 시작됩니다.
관심 있는 개인은 제공된 링크를 통해 등록하여 참여할 수 있습니다. 등록 후 참가자들은 전화 접속 번호, 고유 PIN 번호 및 지침을 받게 됩니다. 이 통화는 Iradimed의 투자자 관계 웹사이트를 통해 실시간으로 이용할 수 있습니다. 회의가 끝난 후에는 회사 웹사이트에서 통화 기록을 확인할 수 있습니다.
IRADIMED (NASDAQ: IRMD) a annoncé sa prochaine conférence téléphonique sur les résultats financiers du deuxième trimestre 2024, prévue pour le 1er août 2024. L'entreprise publiera ses résultats financiers avant l'ouverture du marché ce jour-là. La conférence téléphonique, animée par la direction d'Iradimed, commencera à 12h00 heure de l'Est.
Les personnes intéressées peuvent participer en s'inscrivant via le lien fourni. Une fois inscrits, les participants recevront un numéro de connexion, un code PIN unique et des instructions. L'appel sera également disponible en temps réel sur Internet sur le site Web des relations avec les investisseurs d'Iradimed. Un enregistrement de l'appel sera mis à disposition sur le site de l'entreprise après son achèvement.
IRADIMED (NASDAQ: IRMD) hat seine bevorstehende Telefonkonferenz zu den finanziellen Ergebnissen des zweiten Quartals 2024 für den 1. August 2024 angekündigt. Das Unternehmen wird seine finanziellen Ergebnisse vor der Eröffnung des Marktes an diesem Tag veröffentlichen. Die Telefonkonferenz, die von der Iradimed-Geschäftsleitung geleitet wird, beginnt um 12:00 Uhr Eastern Time.
Interessierte Personen können teilnehmen, indem sie sich über den bereitgestellten Link registrieren. Nach der Registrierung erhalten die Teilnehmer eine Einwahlnummer, eine eindeutige PIN und Anweisungen. Die Konferenz wird auch in Echtzeit über das Internet auf der Investor-Relations-Website von Iradimed verfügbar sein. Eine Aufzeichnung des Anrufs wird nach Abschluss auf der Website des Unternehmens zur Verfügung gestellt.
- None.
- None.
Winter Springs, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 second quarter financial results before the market opens on Thursday, August 1, 2024. Iradimed management will host a conference call the same day beginning at 12:00 p.m. Eastern Time to discuss those results and to answer questions.
Individuals interested in participating in the conference call may do so by registering here, https://register.vevent.com/register/BIa6da8f185c0d4199a6c370fbe9fba158. Once registered, a dial-in number, unique pin, and instructions will be provided to participants.
The conference call will also be available real-time via the internet at http://www.iradimed.com/en-us/investors/events/. A recording of the call will be available on the Company’s website following the completion of the call.
About IRADIMED CORPORATION
IRADIMED CORPORATION is a leader in the development of innovative magnetic resonance imaging (“MRI”) compatible medical devices. We are the only known provider of a non-magnetic intravenous (“IV”) infusion pump system that is specifically designed to be safe for use during MRI procedures. We were the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. Standard infusion pumps contain magnetic and electronic components which can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium® MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe and dependable fluid delivery before, during and after an MRI scan, which is important to critically ill patients who cannot be removed from their vital medications, and children and infants who must generally be sedated to remain immobile during an MRI scan.
Our 3880 MRI compatible patient vital signs monitoring system has been designed with non-magnetic components and other special features to safely and accurately monitor a patient’s vital signs during various MRI procedures. The Iradimed 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The Iradimed 3880 has a compact, lightweight design allowing it to travel with the patient from their critical care unit, to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the Iradimed 3880 include: wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo® algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and; optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The Iradimed 3880 MRI compatible patient vital signs monitoring system has an easy-to-use design and allows for the effective communication of patient vital signs information to clinicians.
Please visit www.iradimed.com for more information.
Media Contact:
John Glenn
Chief Financial Officer
IRADIMED CORPORATION
(407) 677-8022
InvestorRelations@iradimed.com
FAQ
When will IRADIMED (IRMD) release its Q2 2024 financial results?
What time is IRADIMED's Q2 2024 earnings conference call on August 1, 2024?
How can investors participate in IRADIMED's (IRMD) Q2 2024 earnings call?
Will IRADIMED's (IRMD) Q2 2024 earnings call be available online?
